Fri, 21 Sep 2018 11:53:43: uBiome grabs $83M, new digs and Joe Jimenez as it expands into therapeutics

Fri, 21 Sep 2018 11:41:03: Agenus sells cut of Incyte, Merck milestone streams

Fri, 21 Sep 2018 11:35:19: Amgen backs Los Angeles as new Golden State bio hub

Thu, 20 Sep 2018 19:10:38: T-cell therapy for eradicating HIV reservoirs proves safe in small study

Thu, 20 Sep 2018 15:29:29: Chutes & Ladders—Corsico jumps from Boehringer to head development at GlaxoSmithKline

Thu, 20 Sep 2018 13:36:48: Corbus nets over 600 endocannabinoid-related compounds, planning to develop 1-2 per year

Thu, 20 Sep 2018 12:51:58: Trial takes FibroGen’s renal anemia drug closer to EU filing

Thu, 20 Sep 2018 12:00:07: Exicure plans checkpoint combo after TLR9 drug clears early test

Thu, 20 Sep 2018 11:22:27: Amicus joins gene therapy surge with $100M pipeline purchase

Wed, 19 Sep 2018 18:44:38: 3 international charities to fund £30M post-Brexit cancer research model

Wed, 19 Sep 2018 13:17:35: Polverino swaps interim CSO role at Kite for permanent gig at Zymeworks

Wed, 19 Sep 2018 09:59:11: Clovis pays to settle SEC claims about ‘ill-gotten gains’ 

Wed, 19 Sep 2018 09:48:56: Newly identified human skeletal stem cell could lead to bone regenerative therapies

Tue, 18 Sep 2018 14:47:44: Roche tackles clinical trial matching challenge

Tue, 18 Sep 2018 13:34:23: BioTime names new CEO amid leadership shuffle

Tue, 18 Sep 2018 11:38:23: Second former GlaxoSmithKline researcher admits stealing trade secrets

Tue, 18 Sep 2018 11:36:49: Allergan, Sosei halt Alzheimer’s trials amid safety scare

Tue, 18 Sep 2018 11:05:22: Novo to lay off 400 staff in major R&D reorganization

Mon, 17 Sep 2018 18:46:34: Roivant launches lung-focused Respivant with phase 2 IPF drug

Mon, 17 Sep 2018 15:13:48: Servier drops GeNeuro’s multiple sclerosis drug after midphase miss

Mon, 17 Sep 2018 13:49:47: Genentech antibiotic shows broad activity against multidrug-resistant bugs in mice

Mon, 17 Sep 2018 12:19:31: FDA lifts clinical hold from Mersana’s breast cancer trial

Mon, 17 Sep 2018 10:39:46: Realm surrenders after back-to-back clinical defeats

Mon, 17 Sep 2018 08:04:59: Racing UCB and Roivant, Argenx clears phase 2 in primary immune thrombocytopenia

Fri, 14 Sep 2018 14:13:53: FDA sets back review date of Acorda’s levodopa inhaler for Parkinson’s disease